← back to search

Nick Finer

University College Hospital ·
Area of research
Pharmacology · Physiology
Research interest
Research interests include Pharmacology and Obesity Treatment, Diet and metabolism studies, Bariatric Surgery and Outcomes, and Obesity and Health Practices.
h-index
62
citations
14,039
works
363
NIH funding
primary concept
email

Recent publications

Recommendations for real‐world evidence of efficacy and safety of <scp>GLP</scp> ‐1 agonists in Prader‐Willi syndrome: Report of a workshop held by the Foundation for Prader‐Willi Research and International Prader Willi Syndrome Organisation
Diabetes Obesity and Metabolism 2025cited by 1position: firstdoi
COVID‐19 and obesity
Clinical Obesity 2020cited by 116position: firstdoi
Association between fat mass through adolescence and arterial stiffness: a population-based study from The Avon Longitudinal Study of Parents and Children
The Lancet Child & Adolescent Health 2019cited by 68position: middledoi
Obesity and cardiovascular risk
Journal of Hypertension 2018cited by 127position: middledoi
Early vascular damage from smoking and alcohol in teenage years: the ALSPAC study
European Heart Journal 2018cited by 81position: middledoi
Obesity and cardiovascular risk
Journal of Hypertension 2018cited by 61position: middledoi
Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta‐analysis
Obesity Reviews 2016cited by 240position: lastdoi
Drug interventions for the treatment of obesity in children and adolescents
Cochrane Database of Systematic Reviews 2016cited by 162position: middledoi
Effectiveness and cost‐effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease
Diabetes Obesity and Metabolism 2016cited by 10position: lastdoi
An economic model for the use of yoghurt in type 2 diabetes risk reduction in the UK
BMC Nutrition 2016cited by 8position: lastdoi
Influence of sibutramine in addition to diet and exercise on the relationship between weight loss and blood glucose changes
European Heart Journal - Cardiovascular Pharmacotherapy 2016cited by 6position: middledoi
Cardiovascular effects of phentermine and topiramate
Journal of Hypertension 2014cited by 118position: lastdoi
Association between serum bilirubin and cardiovascular disease in an overweight high risk population from the SCOUT trial
Nutrition Metabolism and Cardiovascular Diseases 2014cited by 34position: middledoi
Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease
International Journal of Obesity 2014cited by 30position: middledoi
Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial
International Journal of Obesity 2014cited by 9position: middledoi
Uric Acid as a Risk Factor for Cardiovascular Disease and Mortality in Overweight/Obese Individuals
PLoS ONE 2013cited by 69position: middledoi
Association of Hypoglycemic Treatment Regimens With Cardiovascular Outcomes in Overweight and Obese Subjects With Type 2 Diabetes
Diabetes Care 2013cited by 25position: middledoi
Act now against new NHS competition regulations
BMJ 2013cited by 6position: middledoi
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension
Journal of Hypertension 2012cited by 153position: lastdoi
Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes
Diabetologia 2012cited by 77position: middledoi
Safety and Effectiveness of Meropenem in Infants With Suspected or Complicated Intra-abdominal Infections
Clinical Infectious Diseases 2012cited by 67position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

W. P. T. James · London School of Hygiene & Tropical Medicine9 papers (2012–2016)Ian D. Caterson · Monash University7 papers (2012–2016)Christian Torp‐Pedersen · Danish Diabetes Association6 papers (2012–2016)Arya M. Sharma · York University5 papers (2012–2014)Charlotte Andersson · Harvard University5 papers (2012–2016) · 4 papers (2013–2014)Jens Jordan · Medizinische Hochschule Hannover4 papers (2012–2018)Peter M. Nilsson · Cardiff University3 papers (2012–2018)Guıdo Grassı · Azienda Socio Sanitaria Territoriale Lariana3 papers (2012–2018)Aldo P. Maggioni · Policlinico Umberto I3 papers (2012–2014) · 3 papers (2014–2014)Val Gebski · Centre de recherche en Epidémiologie et Santé des Populations2 papers (2014–2014) · 2 papers (2018–2019)Stella Stabouli · Utrecht University2 papers (2018–2018) · 2 papers (2016–2016) · 2 papers (2018–2018)Tim Lobstein · National Institute of Public Health2 papers (2016–2016)Radhika V. Seimon · Sydney Local Health District2 papers (2014–2014) · 2 papers (2018–2018) · 2 papers (2018–2018)